A Study to Determine the Role of Thea chinensis in Managing Spasmodic and Painful Cramps During Menstruation in Lower Abdomen in Absence of Any Pelvic Pathology.

To Study the Effectiveness of Thea chinensis in the Treatment of Primary Dysmenorrhoea: A Prospective Uncontrolled Experimental Study - NIL

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065469

Enrollment

Registered

2024-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Thea chinensis: Oral administration of Thea chinensis 30C two globules of size 40, dose and repetition- TDS for 3days or as long as the pain persists and Placebo two globules of size 40

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient giving assent/consent for the study. 2. Any 2 symptoms of the patient corresponding to Thea chinensis: ?Soreness and tenderness of right ovary/ovaries. ?Severe cramp like, uterine bearing down pain. ?Pain from beginning to end of period. 3. Diagnostic criteria: Undiagnosed cases will be enrolled after confirming any of 2 following symptoms observed during menstrual period along with lower abdominal/pelvic pain felt at the right and/or left side of the abdomen. ?Pain radiating to the thighs and lower back. ?Nausea and/or vomiting. ?Diarrhoea/constipation. ?Mood disturbances.

Exclusion criteria

Exclusion criteria: 1. Females who are pregnant or lactating. 2. Females suffering from dysmenorrhoea due to Intrauterine Contraceptive Device (IUCDs). 3. Females suffering from dysmenorrhoea due to any pelvic pathology. 4. Patients with other severe systematic disorders. 5. Patients pursing other treatments and are not willing to leave it. 6. Cases requiring emergency/ surgical interventions.

Design outcomes

Primary

Measure	Time frame
Improvement of the score obtained (pre and post treatment) from WaLIDD score.Timepoint: Pre scores will be taken at baseline of treatment and post scores will be assessed at the end of each menstrual cycle till three consecutive cycles.	—

Secondary

Measure	Time frame
To assess the effectiveness of Thea chinensis in pain management in cases of Primary Dysmenorrhoea.Timepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Sristi Chakraborty

Dr MPK Homoeopathic Medical College Hospital and Research Centre

soniatuteja860@gmail.com9530454132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026